Categories Analysis, Leisure & Entertainment

Netflix (NFLX): Is the foundation shaking?

Earlier this week, Netflix Inc. (NASDAQ: NFLX) reported healthy results for the final quarter of 2019 which topped market expectations. Revenue rose 31% coupled with a significant increase in profits. The number of paid members increased 20% to 167 million at the end of the period. The company also saw increases in average revenue per user and average streaming paid memberships.

However, the company saw only 0.42 million paid net adds in the US, possibly due to price changes and the entry of new players in the field. Netflix has been downplaying the impact from the launches of competitive services since last quarter but with more rivals like HBO Max set to enter the space, the risk of losing ground increases.

Netflix reports Q4 2019 earnings results

Disney +, for one, is a rival with a huge library of content which can, going forward, poach more subscribers from Netflix. The same holds true for HBO Max. Although net adds in the US and Canada region were down from the year-ago period at 0.55 million, Netflix said it saw growth in net adds across all the other regions – EMEA, Latin America and Asia-Pacific.

Netflix also changed the way it reports viewership. The company will now calculate views based on users watching the content for two minutes. Most analysts are not pleased with this move and believe this is likely to distort the viewership metrics going forward.

Netflix continues to believe in its strategy of investing in original content and will go on increasing its investments in this area. This will continue to increase its debt load which is another cause of concern. All in all, it appears that going forward we might see a tiny dent in Netflix’s foundation as the competition increases.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top